Canada’s First Clinic Specializing in Ketamine Treatments for Mood Disorders
Established in 2018 Braxia Health (formerly known as CRTCE) offers rapid onset treatments to aid those suffering from several treatment-resistant conditions such as depression and bipolar disorder.
Clinics are located in these ares:
Toronto, Mississauga, Ottawa and Montréal
Canadian Rapid Treatment Center of Excellence
Established in 2018 Braxia Health (formerly known as CRTCE) offers rapid onset treatments to aid those suffering from several treatment-resistant conditions such as depression and bipolar disorder. Our clinic offers a patient oriented approach focused on safety and optimal patient outcomes.
Intravenous (IV) Ketamine
IV ketamine is as an anesthetic medication that is also used for treatment resistant depression. Numerous clinical trials have demonstrated that IV ketamine has rapid and robust antidepressant effects in individuals who continue to suffer from depression, despite trying numerous antidepressant medications and psychotherapy. IV ketamine is used ‘off label’ for depression, meaning that it has not been Health Canada approved for this specific indication.
Oral Ketamine Tablets
Ketamine is compounded into an oral tablet that dissolves under your tongue. Oral ketamine is used off-label for treatment resistant depression. Initial clinical trials have shown promising results; however, oral ketamine is less studied compared to IV ketamine. Oral ketamine is associated with significant dissociative effects, similar to IV ketamine. As such, oral ketamine is administered in the clinic where you are monitored by trained healthcare professionals to ensure a safe and supported treatment experience.
Experienced Team of Specialists and Doctors
Our experienced team of doctors, specialists and clinicians will ensure that your visit at CRTCE is handled with professionalism and confidence. From consultation to treatment we will guide you on your journey with the CRTCE. Are you interested in learning more or getting started? Please contact us to learn more.